Persistence with VKA treatment in newly treated atrial fibrillation patients: an analysis based on a large sample of 38,076 German patients
Crossref DOI link: https://doi.org/10.1007/s00228-017-2307-2
Published Online: 2017-08-05
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wilke, Thomas
Groth, Antje
Fuchs, Andreas
Pfannkuche, Matthias
Maywald, Ulf
Funding for this research was provided by:
Boehringer Ingelheim Pharma GmbH
License valid from 2017-08-05